Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
Julia Niessl(Karolinska Institutet), Daniel E. Kaufmann(University Hospital of Lausanne), Henning Gruell(University of Cologne), Irina Shimeliovich(Rockefeller University), Marina Caskey(Rockefeller University), Allison L. Butler(Rockefeller University), Ching-Lan Lu(Columbia University Irving Medical Center), Pilar Mendoza(Rockefeller University), Yehuda Z. Cohen(Rockefeller University), Amy E. Baxter(Translational Therapeutics (United States)), Mila Janković(Rockefeller University), Michel C. Nussenzweig(Howard Hughes Medical Institute), Florian Klein(University of Cologne), Mathieu Dubé(Centre Hospitalier de l’Université de Montréal)
Cited by 164
Related Papers
Evolution of antibody immunity to SARS-CoV-2
|Nature|2021|1.8k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|801